Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / Interleukin 6
Other

Interleukin 6

Tracked across 1 events · 9 articles · First seen May 20, 2026 · Last active May 29, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Tech
Tocilizumab shows promise for depression
A University of Bristol-led clinical trial, published in JAMA Psychiatry, suggests that Tocilizumab>>>, an anti-inflammatory drug typically used for conditions like Rheumatoid arthritis, may offer a new treatment pathway for difficult-to-treat Depression (mood)>>>. The small…
Impact: Interleukin 6>>> (IL-6) is an inflammatory protein that Tocilizumab>>> blocks, making it a key target in the new approach to treating Depression (mood)>>>.
May 20, 2026 · 9 articles
NEWSDESK
Track Interleukin 6 live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.